Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPLIT nested pilot study of Plasma-Lyte 148 versus 0.9% saline on gastrointestinal function in mechanically ventilated ICU patients
ACTRN12614000269639Phase 4Active, not recruiting
- Sponsor
- Medical Research Institute of New Zealand
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of plasma-lyte and sodium chloride in critical illness (2 arms), sponsored by Medical Research Institute of New Zealand. Primary endpoint: Composite proportion of patients with gastrointestinal complications. Started Apr 2014; status: active, not recruiting.
02
Drugs
plasma-lytesodium chloride
03
Conditions
critical illness
Beyond the preview
Go deeper on ACTRN12614000269639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000269639.